江蘇舜天(600287.SH):高松擬被採取3年證券市場禁入措施
格隆匯7月2日丨江蘇舜天(600287.SH)公佈,2023年6月30日,公司收到中國證券監督管理委員會出具的《行政處罰及市場禁入事先吿知書》(處罰字〔2023〕37號)。
高松的違法情節嚴重,依據《證券法》第二百二十一條和《證券市場禁入規定》(證監會令第185號)第三條第一項、第四條第一款第一項、第五條和第七條的規定,中國證監會擬決定:對高松採取3年證券市場禁入措施。自宣佈決定之日起,在禁入期間內,除不得繼續在原機構從事證券業務、證券服務業務或者擔任原證券發行人的董事、監事、高級管理人員職務外,也不得在其他任何機構中從事證券業務、證券服務業務或者擔任其他證券發行人的董事、監事、高級管理人員職務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.